MicroRNAs (miRNAs) are widely referred to as gene regulators for different diseases. Single nucleotide polymorphism (SNP) in miRNA genes affects miRNA transcription, maturation, target specificity, and interaction, contributing to coronary heart disease (CHD). The current case-control study was designed to determine the role of rs2292832, rs3746444, rs11614913, rs1044165, and rs767649 as risk factors for CHD in the Pakistani population using TaqMan Assay. This case-control study aimed to investigate the association of five miRNA SNPs–rs2292832, rs3746444, rs11614913, rs1044165, and rs767649–with CHD risk in the Pakistani population using the TaqMan assay. Among these, rs3746444 showed a significant association with CHD under co-dominant, dominant, heterozygous, and additive inheritance models. Similarly, rs11614913 was linked to CHD under co-dominant, dominant, recessive, and additive models. The SNP rs767649 was associated with CHD across co-dominant, dominant, recessive, heterozygous, and additive models. A strong association between rs1044165 and CHD was observed under the heterozygous model. Variants in MIR499A, MIR196A2, MIR155, and MIR223 emerged as significant genetic risk factors for CHD, whereas MIR149 did not show a meaningful association in this cohort. These findings suggest a potential role of miRNA polymorphisms in CHD pathogenesis; however, further studies with larger sample sizes are required to validate these associations.
Keywords: microRNA, single nucleotide polymorphism, coronary heart disease, TaqMan Assay
Full text and supplemented materials
References
Abdelghany, W.M., et al., Pre-microRNAs single nucleotide variants (rs3746444 A> G and rs2910164 C> G) increase the risk of ischemic stroke in the Egyptian population: a case–control study, Egypt. J. Med. Hum. Genet., 2022, vol. 23, no. 1, pp. 1–10. https://doi.org/10.1186/s43042-022-00243-7
Agiannitopoulos, K., et al., miRNA polymorphisms and risk of premature coronary artery disease, Hellenic J. Cardiol., 2021, vol. 62, no. 4, pp. 278–284. https://doi.org/10.1016/j.hjc.2020.01.005
Ali, H.M., et al., Study the association of microRNA polymorphisms (miR-146a, miR-4513) with the risk of coronary heart diseases in Egyptian population, J. Biochem. Mol. Toxicol., 2023, vol. 37, no. 3, p. e23284. https://doi.org/10.1002/jbt.23284
Buttar, H.S., T. Li, and Ravi, N., Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation, Exp. Clin. Cardiol., 2005, vol. 10, no. 4, pp. 229–249. https://pmc.ncbi.nlm.nih.gov/articles/PMC2716237/
Chen, J., et al., mir-17–92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts, Circ. Res., 2013, vol. 112, no. 12, pp. 1557–1566. https://doi.org/10.1161/circresaha.112.300658
Chin, L.J., et al., A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk, Cancer Res., 2008, vol. 68, no. 20, pp. 8535–8540. https://doi.org/10.1158/0008-5472.can-08-2129
Duan, R., Pak, C., and Jin, P., Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA, Hum. Mol. Genet., 2007, vol. 16, no. 9, pp. 1124–1131. https://doi.org/10.1093/hmg/ddm062
Eren, N.K., et al., Does MicroRNA Profile Differ in Early Onset Coronary Artery Disease?, Turk Kardiyol. Dernegi Arsivi, 2022, vol. 50, no. 6, p. 407. https://doi.org/10.5543/tkda.2022.22408
Fawzy, M.S., et al., Association of MIR-499a expression and seed region variant (rs3746444) with cardiovascular disease in Egyptian patients, Acta Cardiol., 2018, vol. 73, no. 2, pp. 131–140. https://doi.org/10.1080/00015385.2017.1351243
Gao, H., et al., Plasma Levels of microRNA-145 Are associated with severity of coronary artery disease, PLoS One, 2015, vol. 10, no. 5, p. e012347. https://doi.org/10.1371/journal.pone.0123477
Georges, M., Coppieters, W., and Charlier, C., Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease, Curr. Opin. Genet. Dev., 2007, vol. 17, no. 3, pp. 166–176. https://doi.org/10.1016/j.gde.2007.04.005
Ghaffarzadeh, M., et al., Association of MiR-149 (RS2292832) variant with the risk of coronary artery disease, J. Med. Biochem., 2017, vol. 36, no. 3, pp. 251–258. https://doi.org/10.1515/jomb-2017-0005
Grootaert, M.O. and M.R. Bennett., Vascular smooth muscle cells in atherosclerosis: time for a re-assessment, Cardiovasc. Res., 2021, vol. 117, no. 11, pp. 2326–2339. https://doi.org/10.1093/cvr/cvab046
Guo, R., et al., Association of a MiR-499 SNP and risk of congenital heart disease in a Chinese population, Cell Mol. Biol., 2018, vol. 64, no. 10, pp. 108–112. https://pubmed.ncbi.nlm.nih.gov/30084801/
Hinton, R.B., Genetic and environmental factors contributing to cardiovascular malformation: a unified approach to risk, J. Am. Heart Assoc., 2013, vol. 2, no. 3, p. e000292. https://doi.org/10.1161/JAHA.113.000292
Horikawa, Y., et al., Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma, Clin. Cancer Res., 2008, vol. 14, no. 23, pp. 7956–62. https://doi.org/10.1158/1078-0432.ccr-08-1199
Huang, S., et al., A Genetic Variant in Pre-miR-146a (rs2910164 C>G) Is Associated with the Decreased Risk of Acute Coronary Syndrome in a Chinese Population, Tohoku J. Exp. Med., 2015, vol. 237, no. 3, pp. 227–233. https://doi.org/10.1620/tjem.237.227
Huang, H.Y., et al., miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database, Nucleic Acids Res., 2020, vol. 48, no. D1, pp. D148–D154. https://doi.org/10.1093/nar/gkz896
Human Experimentation: Code of Ethics of the World Medical Association (Declaration of Helsinki), Can. Med. Assoc. J., 1964, vol. 91, no. 11, p. 619. https://pmc.ncbi.nlm.nih.gov/articles/PMC1927433/
Jazdzewski, K., et al., Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma, Proc. Natl. Acad. Sci. U. S. A., 2008, vol. 105, no. 20, pp. 7269–7274. https://doi.org/10.1073/pnas.0802682105
Kalayinia, S., et al., MicroRNAs: roles in cardiovascular development and disease, Cardiovasc. Pathol., 2021, vol. 50, p. 107296. https://doi.org/10.1016/j.carpath.2020.107296
Kargutkar, N., Hariharan, P., and Nadkarni, A., Dynamic interplay of microRNA in diseases and therapeutic, Clin. Genet., 2023, vol. 103, no. 3, pp. 268–276. https://doi.org/10.1111/cge.14256
Kaur, A., et al., Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease, Cardiovasc. Res., 2020, vol. 116, no. 6, pp. 1113–1124. https://doi.org/10.1093/cvr/cvz302
Kennel, P.J. and Schulze, P.C., A Review on the Evolving Roles of MiRNA-Based Technologies in Diagnosing and Treating Heart Failure, Cells, 2021, vol. 10, no. 11. https://doi.org/10.3390/cells10113191
Kozomara, A., Birgaoanu, M., and Griffiths-Jones, S., miRBase: from microRNA sequences to function, Nucleic Acids Res., 2019, vol. 47, no. D1, pp. D155–D162. https://doi.org/10.1093/nar/gky1141
Labbaf, A., et al., The pre-mir-499 variant rs3746444 may contribute to coronary artery disease susceptibility: a case-control and meta-analysis study, Clin. Lab., 2017, vol. 63, no. 3, pp. 587–595. https://doi.org/10.7754/clin.lab.2016.161011
Liu, S., et al., Molecular mechanisms in vascular injury induced by hypertension: Expression and role of microRNA-34a, Exp. Ther. Med., 2017, vol. 14, no. 6, pp. 5497–5502. https://doi.org/10.3892/etm.2017.5216
Liu, X., et al., Significant association between functional microRNA polymorphisms and coronary heart disease susceptibility: a comprehensive meta-analysis involving 16484 subjects, Oncotarget, 2017, vol. 8, no. 4, pp. 5692–5702. https://doi.org/10.18632/oncotarget.14249
Lorenz, R., et al., ViennaRNA Package 2.0. Algorithms, Mol. Biol., 2011, vol. 6, p. 26. https://doi.org/10.1186/1748-7188-6-26
Martinez-Arroyo, O., et al., Prognostic value of microrna-126-3p for cardiovascular events in a general population, J. Hypertens., 2023, vol. 41, p. e39. https://doi.org/10.1097/01.hjh.0000939216.43221.0e
Marzilli, M., et al., Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!, J. Am. Coll. Cardiol., 2012, vol. 60, no. 11, pp. 951–956. https://doi.org/10.1016/j.jacc.2012.02.082
Masoodi Khabar, P., et al., Platelet microRNA-484 as a novel diagnostic biomarker for acute coronary syndrome, Lab. Med., 2023, vol. 54, no. 3, pp. 256–261. https://doi.org/10.1093/labmed/lmac102
Peng, C., et al., A microRNA-related single nucleotide polymorphism of the Dicer gene is associated with risk of dermatomyositis, Eur. J. Inflam., 2023, vol. 21. https://doi.org/10.1177/1721727X231173526
Pradhan, K., et al., MicroRNA-21 mediated cross-talk between cardiomyocytes and fibroblasts in patients with atrial fibrillation, Front. Cardiovasc. Med., 2023, vol. 10, p. 1056134. https://doi.org/10.3389/fcvm.2023.1056134
Raitoharju, E., et al., miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study, Atherosclerosis, 2011, vol. 219, no. 1, pp. 211–217. https://doi.org/10.1016/j.atherosclerosis.2011.07.020
Ren, N., et al., Strategies for activity analysis of single nucleotide polymorphisms associated with human diseases, Clin. Genet., 2023, vol. 103, no. 4, pp. 392–400. https://doi.org/10.1111/cge.14282
Ryan, B.M., Robles, A.I., and Harris, C.C., Genetic variation in microRNA networks: the implications for cancer research, Nat. Rev. Cancer., 2010, vol. 10, no. 6, pp. 389–402. https://doi.org/10.1038/nrc2867
Shang, F., et al., Endothelial microrna-483-3p is hypertension-protective, Oxid. Med. Cell. Longevity, 2022, vol. 2022, p. 13. https://doi.org/10.1155/2022/3698219
Slaby, O., et al., Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer, J. Cell Mol. Med., 2012, vol. 16, no. 1, pp. 8–21. https://doi.org/10.1111/j.1582-4934.2011.01359.x
Sondermeijer, B.M., et al., Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*, PLoS One, 2011, vol. 6, no. 10, p. e25946. https://doi.org/10.1371/journal.pone.0025946
Sung, J.H., et al., miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease, Mol. Med. Rep., 2016, vol. 14, no. 3, pp. 2328–2342. https://doi.org/10.3892/mmr.2016.5495
Thakkinstian, A., et al., A method for meta-analysis of molecular association studies, Stat. Med., 2005, vol. 24, no. 9, pp. 1291–1306. https://doi.org/10.1002/sim.2010
Ventura, A., et al., Targeted deletion reveals essential and overlapping functions of the miR-17∼ 92 family of miRNA clusters, Cell, 2008, vol. 132, no. 5, pp. 875–886. https://doi.org/10.1016/j.cell.2008.02.019
Wang, D. and Yan, C., MicroRNA-208a-3p participates in coronary heart disease by regulating the growth of hVSMCs by targeting BTG1, Exp. Ther. Med., 2022, vol. 23, no. 1, p. 71. https://doi.org/10.3892/etm.2021.10994
Writing Group, M., et al., Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association, Circulation, 2016, vol. 133, no. 4, pp. e38–360. https://doi.org/10.1161/cir.0000000000000350
Wronska, A., The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments, J. Pharmacol. Exp. Ther., 2023, vol. 384, no. 1, pp. 123–132. https://doi.org/10.1124/jpet.121.001152
Xu, J., et al., Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population, Hum. Mutat., 2009, vol. 30, no. 8, pp. 1231–1236. https://doi.org/10.1002/humu.21044
Yang, Y., et al., Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review, Herz, 2022, vol. 47, no. 6, pp. 524–535. https://doi.org/10.1007/s00059-021-05086-3
Zhang, C., MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease, Cell Cycle, 2009, vol. 8, no. 21, pp. 3469–3473. https://doi.org/10.4161/cc.8.21.9837
Zhi, H., et al., Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease, Clin. Res. Cardiol., 2012, vol. 101, no. 4, pp. 289–296. https://doi.org/10.1007/s00392-011-0391-3